Ponoi Management, LLC
- SEC CIK
- 0001720702
- Latest filing
- Nov 14, 2022
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 17, 2021. Long positions only.
- Positions
- 5
- No 13F data for Q4 2020
- Portfolio value
- $170.0M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNSTConstellation Pharmaceuticals Inc | COM | 1,880,623 | $44.0M | 25.9% | – | – | History |
| NGMNGM Biopharmaceuticals Inc | COM | 1,298,908 | $37.8M | 22.2% | – | – | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,599,417 | $35.5M | 20.9% | – | – | History |
| RVMDRevolution Medicines, Inc. | COM | 685,011 | $31.4M | 18.5% | – | – | History |
| NRIXNurix Therapeutics, Inc. | COM | 686,274 | $21.3M | 12.5% | – | – | History |